ChartRow logo
Data provided bySource: Twelve Data
ENSG
$186.02-1.17%
as of close, Nov 17, 2026
☾ AH $186.02 -1.17%
PeersEHCUHSTHCDVAHCAMOH
Share this page

ENSG — The Ensign Group Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in ENSG be worth today? →
ENSG returns: By year · By month · By week · Trailing

Price data

Price
$186.02
YTD price return
+6.79%
YTD total return
+6.90%
Market cap
10.9B
Enterprise value
12.8B
Shares outstanding
58.3M
52W low
$141.58
52W high
$218.00
From 52W high
-14.67%
From 52W low
+31.39%
52W range
58%$142–$218
Beta
0.69

Volume

Rel volume
0.67×
30D volume
366.5K
30D $ vol
65.8M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
−$18K
Insider net 1Y
−$4.1M

Form 4 transactions by trade date, as filed; latest on file 2026-10-16.

Fundamentals

Sales (ttm)
5.7B
Sales/share
$97.26
EPS (ttm)
$6.72
Book value/share
$43.87
Net margin
7.03%
ROE
15.59%
ROA
6.65%
Debt / equity
0.08×
Current ratio
1.20

Growth (CAGR, ttm) · 10Y

Sales
+17.51%+16.82%+17.23%+13.48%
Net income
+21.62%+17.16%+15.73%+24.32%
FCF
-24.31%+145.32%n/an/a
Shares
+0.72%+1.10%+1.09%+1.42%

Per-share growth (CAGR, ttm) · 10Y

EPS
+20.06%+15.66%+14.70%+22.76%
Sales/share
+16.67%+15.55%+15.96%+11.90%
FCF/share
-25.49%+141.23%n/an/a
Book value/share
+19.91%+19.26%+19.88%+17.68%
Dividend/share
+4.00%+4.17%+4.36%+4.98%
Price
+4.77%+20.09%+17.78%+25.02%
Total return
+4.92%+20.30%+18.02%+25.47%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
27.7×
P/OI (ttm)
21.3×
Fwd P/E
21.5×
P/S (ttm)
1.9×
P/B (mrq)
4.2×
EV/EBITDA (fy)
20.3×
EV/Sales (ttm)
2.2×
Dividend yield (fwd)Div yield
0.14%
Dividend yield (ttm)
0.14%
Dividend/share (fwd)
$0.26
Buyback yield (realized, 1y)
-0.72%
Shareholder yield (realized, 1y)
-0.57%
Buyback yield (cash, ttm)
0.44%
Shareholder yield (cash, ttm)
0.58%

Vs own 10Y history

P/E
70th
P/OI
69th
P/S
83rd
P/B
59th
P/FCF
12th

Bar = where today’s multiple sits in ENSG’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-17#

Data provided bySource: Twelve Data
1D
-1.17%
5D
+0.50%
1M
+5.32%
3M
+2.47%
YTD
+6.79%
1Y
+4.76%
5Y
+126.60%
1D
-1.17%
5D
+0.50%
1M
+5.32%
3M
+2.51%
YTD
+6.90%
1Y
+4.92%
5Y
+128.95%

Fundamentals#

Revenue

5Y CAGR +16.1%5Y CAGR +16.1%YoY +14.5%
$5.7B TTM$1.5B Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +13.8%10Y CAGR +16.4%YoY +43.4%
$509.2M TTM$138M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +13.8%10Y CAGR +18.6%YoY +23.9%
$6.72 TTM$1.76 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +31.1%10Y CAGR +17.3%YoY +21.2%
— FY25— Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

FY25: operating cash flow $564.3M, capex —

Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $240.2M, capex —

Shares (diluted)

5Y +5.5%10Y +12.8%YoY +0.6%
59.4M TTM59.3M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +4.5%10Y CAGR +5.2%YoY +4.0%
$0.26 TTM$0.07 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full ENSG financials →

The Ensign Group, Inc. is a healthcare services holding company that provides post-acute care through independent operating subsidiaries. The company focuses on skilled nursing, rehabilitation, and senior living services, including physical, occupational, and speech therapy, as well as related healthcare support services. It also operates ancillary businesses such as mobile diagnostics and medical transportation, and it acquires, leases, and owns healthcare real estate tied to the post-acute care continuum. The Ensign Group serves patients and residents across multiple U.S. states through a decentralized operating model, making it a notable participant in skilled care, long-term care, and healthcare property services. Headquartered in San Juan Capistrano, California, and founded in 1999, The Ensign Group plays a significant role in delivering care for aging and medically complex populations.

San Juan Capistrano, CA·46,000 employees·Medical Care Facilities·ensigngroup.net·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding ENSG#

21 of the 193 ETFs ChartRow carries live hold ENSG. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
VBKVanguard Small-Cap Growth ETF0.3%
IJHiShares Core S&P Mid-Cap ETF0.3%
MDYSPDR S&P MidCap 400 ETF Trust0.3%
VHTVanguard Health Care ETF0.1%
VBVanguard Small-Cap ETF0.1%
VXFVanguard Extended Market ETF0.1%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
TickerName1M1D
LLYEli Lilly and Company+12.61%-1.13%
JNJJohnson & Johnson+9.05%-1.36%
ABBVAbbVie Inc.+2.59%-0.59%
MRKMerck & Co. Inc.-1.77%-0.75%
UNHUnitedHealth Group Incorporated Common Stock (DE)-2.93%-5.42%
NVSNovartis AG+5.65%-0.67%
TMOThermo Fisher Scientific Inc.-0.47%-0.66%
AMGNAmgen Inc.+5.88%-0.95%